연구성과로 돌아가기

2024 연구자 정보 (468 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Song, Soo Min
(Song, SM)
Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea
0000-0002-3648-9632
Song, Soomin
[JCR상위 18.2] The clinical course of hospitalized COVID-19 patients and aggravation risk prediction models: a retrospective, multi-center Korean cohort study SCIE 18.2 MEDICINE, GENERAL & INTERNAL ksw2kms@knu.ac.kr;tspark@stats.snu.ac.kr;
Sugihara, Masahiro
(Sugihara, M)
Daiichi Sankyo Co Ltd, Tokyo, Japan

[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY tsurutaj@med.showa-u.ac.jp;
Taira, Tetsuhiko
(Taira, T)
Hakuaikai Social Med Corp, Sagara Hosp, Dept Med Oncol, Kagoshima, Japan

[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY mjkwon94@knu.ac.kr;yas794@mail.harvard.edu;
Teraoka, Megumi
(Teraoka, M)
Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan

[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY mjkwon94@knu.ac.kr;yas794@mail.harvard.edu;
Tokunaga, Eriko
(Tokunaga, E)
NHO Kyushu Canc Ctr, Fukuoka, Japan

[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY tsurutaj@med.showa-u.ac.jp;
Tsurutani, Junji
(Tsurutani, J)
교신저자 Showa Univ Hosp, Innovat Ctr Translat Res & Clin Sci Canc Therapy, Tokyo, Japan
Showa Univ, Adv Canc Translat Res Inst, Tokyo, Japan


[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY tsurutaj@med.showa-u.ac.jp;
Wang, Xiaojia
(Wang, XJ)
Zhejiang Canc Hosp, Hangzhou, Peoples R China

[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY tsurutaj@med.showa-u.ac.jp;
Xu, Binghe
(Xu, BH)
Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Beijing, Peoples R China

[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study SCIE 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY tsurutaj@med.showa-u.ac.jp;
Yamashita, Toshinari
(Yamashita, T)
제1저자 Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
Kanagawa Canc Ctr, Yokohama, Japan


[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
[JCR상위 0.3] Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial
[JCR상위 0.3] Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024)
SCIE 0.3 OBSTETRICS & GYNECOLOGY;ONCOLOGY
BIOCHEMISTRY & MOLECULAR BIOLOGY;CELL BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL
tsurutaj@med.showa-u.ac.jp;
meng.li7@pfizer.com;patricia.lorusso@yale.edu;
Yeo, Jin Song
(Yeo, JS)
Kyungpook Natl Univ, Sch Med, Dept Anesthesia & Pain Med, Daegu, South Korea

[JCR상위 18.2] NKG2D (Natural Killer Group 2, Member D) ligand expression and ameloblastoma recurrence: a retrospective immunohistological pilot study SCIE 18.2 DENTISTRY, ORAL SURGERY & MEDICINE jseanes@knu.ac.kr;
Ahn, Changhwan
(Ahn, C)
Jeju Natl Univ, Coll Vet Med, Lab Vet Physiol, Jeju 63243, South Korea

[JCR상위 18.3] Glucocorticoid-Dependent Retinal Degeneration and Vision Impairment in Mice Susceptible to Prenatal Stress-Induced Behavioral Abnormalities SCIE 18.3 CELL BIOLOGY;NEUROSCIENCES choige@jejunu.ac.kr;
Choi, Gee Euhn
(Choi, GE)
교신저자 Jeju Natl Univ, Vet Med Res Inst, Jeju 63243, South Korea
Jeju Natl Univ, Coll Vet Med, Lab Vet Biochem, Jeju 63243, South Korea
Jeju Natl Univ, Interdisciplinary Grad Program Adv Convergence Tec, Jeju 63243, South Korea


[JCR상위 18.3] Glucocorticoid-Dependent Retinal Degeneration and Vision Impairment in Mice Susceptible to Prenatal Stress-Induced Behavioral Abnormalities SCIE 18.3 CELL BIOLOGY;NEUROSCIENCES choige@jejunu.ac.kr;
Jung, Ji-Youl
(Jung, JY)
Jeju Natl Univ, Coll Vet Med, Jeju 63243, South Korea
Jeju Natl Univ, Vet Med Res Inst, Jeju 63243, South Korea


[JCR상위 18.3] Glucocorticoid-Dependent Retinal Degeneration and Vision Impairment in Mice Susceptible to Prenatal Stress-Induced Behavioral Abnormalities SCIE 18.3 CELL BIOLOGY;NEUROSCIENCES choige@jejunu.ac.kr;
Kim, Myung-Chul
(Kim, MC)
Jeju Natl Univ, Coll Vet Med, Vet Lab Med, Clin Pathol, Jeju 63243, South Korea
Jeju Natl Univ, Res Inst Vet Med, Coll Vet Med, Jeju 63243, South Korea


[JCR상위 18.3] Glucocorticoid-Dependent Retinal Degeneration and Vision Impairment in Mice Susceptible to Prenatal Stress-Induced Behavioral Abnormalities SCIE 18.3 CELL BIOLOGY;NEUROSCIENCES choige@jejunu.ac.kr;
Oh, Ji Young
(Oh, JY)
Korea Inst Hlth, Div Intractable Dis Res, Cheongju 28106, South Korea

[JCR상위 18.3] Glucocorticoid-Dependent Retinal Degeneration and Vision Impairment in Mice Susceptible to Prenatal Stress-Induced Behavioral Abnormalities SCIE 18.3 CELL BIOLOGY;NEUROSCIENCES choige@jejunu.ac.kr;
페이지 이동: